Bioness Inc.

Bioness Inc. , based in the US, specializes in developing advanced medical technologies designed to enhance rehabilitation outcomes for individuals recovering from various neurological impairments. Bioness Inc. is focused on creating innovative solutions for rehabilitation therapy.

Founded in 2004, the company is headquartered in Valencia, California, US. In its history, Bioness underwent a strategic pivot to enhance its product offerings and recently raised USD 110. 00 mn through an ADD-ON funding round led by Bioventus LLC. The company has completed a total of 2 deals.

Bioness Medical, Inc. specializes in advanced medical technologies that enhance rehabilitation outcomes for those recovering from neurological impairments such as strokes and brain injuries. Their key products include the Bioness Integrated Therapy System (BITS), L300 Go system, H200 Wireless Hand Rehabilitation System, and Vector Gait and Safety System. BITS is a software-based platform that assesses and tracks patient deficiencies, while the L300 Go system uses functional electrical stimulation (FES) for gait improvement.

The H200 Wireless system restores hand function through FES, and the Vector system provides body weight support for safe rehabilitation exercises. Bioness caters to rehabilitation facilities, clinicians, and patients primarily in North America, Europe, and select Asia-Pacific markets. Bioness Medical, Inc. derives its revenue primarily from the sale of rehabilitation devices and systems to healthcare providers and rehabilitation centers.

Their business model focuses on direct sales and strategic partnerships, with products such as the L300 Go and H200 Wireless systems being integrated into therapeutic programs. Clients typically purchase these systems outright, with maintenance and training services offered as additional revenue streams. The pricing of these trademarked products aligns with industry standards for medical devices, reflecting their technological advancements and therapeutic benefits, and emphasizes long-term relationships with healthcare providers. Bioness Inc.

, after being acquired by GlenRock Israel, aims to expand its product line and enter new markets. The company is actively working on the development of new rehabilitation technologies intended for launch in the upcoming year, targeting regions such as Europe and Asia-Pacific for broader market penetration. The recent funding of USD 110. 00 mn will be utilized to accelerate product development and support market expansion strategies.